China Universal China Universal Hang Seng H K - Listed Biotechnology Index ETF (SHA:513280)
China · Delayed Price · Currency is CNY 1.324
-0.020 (-1.49%)
At close: Sep 23, 2025
-1.49% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | 13.75 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +109.16% |
| Volume | 94,439,300 |
| Open | 1.344 |
| Previous Close | 1.344 |
| Day's Range | 1.306 - 1.349 |
| 52-Week Low | 0.611 |
| 52-Week High | 1.406 |
| Beta | n/a |
| Holdings | 53 |
| Inception Date | May 7, 2022 |
About 513280
513280.SS was created on 2022-05-07 by China Universal. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, and pursue the minimization of tracking deviation and tracking error.
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 513280
Provider China Universal
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Gross
Performance
513280 had a total return of 109.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.38%.
Top 10 Holdings
60.73% of assets| Name | Symbol | Weight |
|---|---|---|
| Innovent Biologics, Inc. | 1801 | 10.91% |
| WuXi Biologics (Cayman) Inc. | 2269 | 9.35% |
| BeOne Medicines AG | 6160 | 8.85% |
| CSPC Pharmaceutical Group Limited | 1093 | 6.13% |
| Akeso, Inc. | 9926 | 6.08% |
| Sino Biopharmaceutical Limited | 1177 | 5.35% |
| 3SBio Inc. | 1530 | 4.47% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 3.47% |
| Cash | n/a | 3.16% |
| Zai Lab Limited | 9688 | 2.97% |